These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12090799)

  • 1. The virucidal spectrum of a high concentration alcohol mixture.
    van Engelenburg FA; Terpstra FG; Schuitemaker H; Moorer WR
    J Hosp Infect; 2002 Jun; 51(2):121-5. PubMed ID: 12090799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.
    Terpstra FG; Parkkinen J; Tölö H; Koenderman AH; Ter Hart HG; von Bonsdorff L; Törmä E; van Engelenburg FA
    Vox Sang; 2006 Jan; 90(1):21-32. PubMed ID: 16359352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of surface-dried virus to common disinfection procedures.
    Terpstra FG; van den Blink AE; Bos LM; Boots AG; Brinkhuis FH; Gijsen E; van Remmerden Y; Schuitemaker H; van 't Wout AB
    J Hosp Infect; 2007 Aug; 66(4):332-8. PubMed ID: 17601636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.
    Terpstra FG; van 't Wout AB; Schuitemaker H; van Engelenburg FA; Dekkers DW; Verhaar R; de Korte D; Verhoeven AJ
    Transfusion; 2008 Feb; 48(2):304-13. PubMed ID: 18028277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability of vaccinia virus and bovine viral diarrhea virus (BVDV) for determining activities of three commonly-used alcohol-based hand rubs against enveloped viruses.
    Kampf G; Steinmann J; Rabenau H
    BMC Infect Dis; 2007 Feb; 7():5. PubMed ID: 17291338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral safety of C1-inhibitor NF.
    Terpstra FG; Kleijn M; Koenderman AH; Over J; van Engelenburg FA; Schuitemaker H; van 't Wout AB
    Biologicals; 2007 Jun; 35(3):173-81. PubMed ID: 17071103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
    Borovec S; Broumis C; Adcock W; Fang R; Uren E
    Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry.
    Lazo A; Tassello J; Jayarama V; Ohagen A; Gibaja V; Kramer E; Marmorato A; Billia-Shaveet D; Purmal A; Brown F; Chapman J
    Vox Sang; 2002 Nov; 83(4):313-23. PubMed ID: 12437518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine.
    Gugerell A; Sorgenfrey D; Laggner M; Raimann J; Peterbauer A; Bormann D; Suessner S; Gabriel C; Moser B; Ostler T; Mildner M; Ankersmit HJ
    Blood Transfus; 2020 Jan; 18(1):30-39. PubMed ID: 30865581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms.
    Burnouf T; Terpstra F; Habib G; Seddik S
    Biologicals; 2007 Oct; 35(4):329-34. PubMed ID: 17363271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses.
    Pruss A; Kao M; Gohs U; Koscielny J; von Versen R; Pauli G
    Biologicals; 2002 Jun; 30(2):125-33. PubMed ID: 12127314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-inhibiting surgical glove to reduce the risk of infection by enveloped viruses.
    Bricout F; Moraillon A; Sonntag P; Hoerner P; Blackwelder W; Plotkin S
    J Med Virol; 2003 Apr; 69(4):538-45. PubMed ID: 12601762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo efficacy of hand sanitisers against feline calicivirus: a surrogate for norovirus.
    Lages SL; Ramakrishnan MA; Goyal SM
    J Hosp Infect; 2008 Feb; 68(2):159-63. PubMed ID: 18207605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity.
    Poelsler G; Berting A; Kindermann J; Spruth M; Hämmerle T; Teschner W; Schwarz HP; Kreil TR
    Vox Sang; 2008 Apr; 94(3):184-192. PubMed ID: 18167162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus safety of avital bone tissue transplants: evaluation of sterilization steps of spongiosa cuboids using a peracetic acid-methanol mixture.
    Pruss A; Kao M; Kiesewetter H; von Versen R; Pauli G
    Biologicals; 1999 Sep; 27(3):195-201. PubMed ID: 10652175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of viral cross-infection. Surface disinfection with 80% ethanol].
    Moorer WR
    Ned Tijdschr Tandheelkd; 2003 Oct; 110(10):399-402. PubMed ID: 14606247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ethanol against viruses in hand disinfection.
    Kampf G
    J Hosp Infect; 2018 Apr; 98(4):331-338. PubMed ID: 28882643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of viral inactivation of pseudorabies virus, encephalomyocarditis virus, bovine viral diarrhea virus and porcine parvovirus in pancreatin of porcine origin.
    Caruso C; Gobbi E; Biosa T; Andra' M; Cavallazzi U; Masoero L
    J Virol Methods; 2014 Nov; 208():79-84. PubMed ID: 25110118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
    Goldsmith JC
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus safety of a porcine-derived medical device: evaluation of a viral inactivation method.
    Hodde J; Hiles M
    Biotechnol Bioeng; 2002 Jul; 79(2):211-6. PubMed ID: 12115437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.